Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The answer from PTSC to the USPTO contingency is .....

The answer from PTSC to the USPTO contingency is .....

posted on May 15, 2008 06:20AM

My question forwarded to PTSC through Ken at Hawk;

"Are any company's payments for granted or purchased MMP licenses to date contingent on the USPTO re-examination results?"

Answer from PTSC;

"There have not been any such contingencies."

I guess that answers the USPTO contingency question.

All the best,

Steve

Share
New Message
Please login to post a reply